Hepatitis C virus NS5A-regulated gene expression and signaling revealed via microarray and comparative promoter analyses

Hepatology

Volumn 40, Issue 3, 2004, Pages 708-718

  Girard, Sophie ^a   Vossman, Erik ^a   Misek, David E ^a   Podevin, Philippe ^b,c   Hanash, Samir ^a   Bréchot, Christian ^b   Beretta, Laura ^a,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b INSERM   (France)

^c Cochin Hospital ^*  (France)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; LUCIFERASE; LYMPHOTOXIN BETA; LYMPHOTOXIN BETA RECEPTOR; RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; ALPHA INTERFERON; CALCIUM; CARRIER PROTEIN; INTERLEUKIN 1; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; SIGNAL PEPTIDE; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA1; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; BINDING SITE; CALCIUM HOMEOSTASIS; CELL ADHESION; CELL MOTILITY; CONSENSUS SEQUENCE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DNA MICROARRAY; GENE EXPRESSION REGULATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIPID METABOLISM; LIPID TRANSPORT; LIVER DISEASE; LIVER FIBROSIS; NUCLEOTIDE SEQUENCE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; AMINO ACID SEQUENCE; GENE EXPRESSION PROFILING; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY;

AMINO ACID SEQUENCE; BINDING SITES; CALCIUM; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; HEPATITIS C; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-1; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LATENT TGF-BETA BINDING PROTEINS; LIPID METABOLISM; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VIRAL NONSTRUCTURAL PROTEINS;

EID: 4544275336     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20371     Document Type: Article

References (48)

1. Alter MJ. Epidemiology of hepatitis C. HEPATOLOGY 1997;26:62S-65S.
2. Reed KE, Rice CM. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 2000;242:55-84.
3. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 1995;96:224-230.
4. Gale MJJ, Korth MJ, Tang NM, Tan SL, Hopkins DA, Dever TE, et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997;230:217-227.
5. Paterson M, Laxton C, Thomas H, Ackrill A, Foster G. Hepatitis C virus NS5A protein inhibits Interferon antiviral activity, but the effects do not correlate with clinical response. Gastroenterology 1999;117:1187-1197.
6. Pawlotsky JM, Germanidis G, Neumann AU, Pellerin M, Frainais PO, Dhumeaux D. Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J Virol 1998;72:2795-2805.
7. Podevin P, Sabile A, Gajardo R, Delhem N, Abadie A, Lozach PY, et al. Expression of hepatitis C virus NS5A natural mutants in an hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner. HEPATOLOGY 2001;33:1503-1511.
8. Girard S, Shalhoub P, Lescure P, Sabile A, Misek DE, Hanash S, et al. An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology 2002;295:272-283.
9. Polyak SJ, Khabar KS, Paschal DM, Ezelle HJ, Duverlie G, Barber GN, et al. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol 2001;75:6095-6106.
10. Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000;290:1972-1974.
11. Krieger N, Lohmann V, Bartenschlager R. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 2001;75:4614-4624.
12. Shirota Y, Luo H, Qin W, Kaneko S, Yamashita T, Kobayashi K, et al. Hepatitis C virus NS5A binds RNA-dependent RNA polymerase NS5B and modulates RdRP activity. J Biol Chem 2002;277:11149-11155.
13. Tu H, Gao L, Shi ST, Taylor DR, Yang T, Mircheff AK, et al. Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology 1999;263:30-41.
14. Elazar M, Cheong KH, Liu P, Greenberg HB, Rice CM, Glenn JS. Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication. J Virol 2003;77:6055-6061.
15. Kato N, Lan KH, Ono-Nita SK, Shiratori Y, Omata M. Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. J Virol 1997;71:8856-8859.
16. Kel AE, Goßling E, Reuter I, Cheremushkin E, Kel-Margoulis QV, Wingender E. MATCH™: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res 2003;31:3576-3579.
17. Wingender E, Chen X, Fricke E, Geffers R, Hehl R, Liebich I, et al. The TRANSFAC system on gene expression regulation. Nucleic Acids Res 2001;29:281-283.
18. Thompson W, Rouchka EC, Lawrence CE. Gibbs Recursive Sampler: finding transcription factor binding sites. Nucleic Acids Res 2003;31:3580-3585.
19. Bigger CB, Brasky KM, Lanford RE. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 2001;75:7059-7066.
20. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am J Pathol 2002;160:641-654.
21. Wood JR, Melia WM, Wood SM, Wilkinson ML, Lee YC, Portmann B, et al. Neurotensin and hepatocellular carcinoma. Lancet 1984;1:687.
22. Harada K, Shiota G, Kawasaki H. Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma. Liver 1999;19:318-325.
23. Lee KW, Ko BC, Jiang Z, Cao D, Chung SS. Overexpression of aldose reductase in liver cancers may contribute to drug resistance. Anticancer Drugs 2001b;12:129-132.
24. Gotoh M, Sakamoto M, Kanetaka K, Chuuma M, Hirohashi S. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int 2002;52:19-24.
25. Miyasaka Y, Enomoto N, Nagayama K, Izumi N, Marumo F, Watanabe M, et al. Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization. Br J Cancer 2001;85:228-234.
26. Genda T, Sakamoto M, Ichida T, Asakura H, Kojiro M, Narumiya S, et al. Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. HEPATOLOGY 1999;30:1027-1036.
27. Ito Y, Sasaki Y, Horimoto M, Wada S, Tanaka Y, Kasahara A, et al. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma. HEPATOLOGY 1998;27:951-958.
28. Miyazono K, Olofsson A, Colosetti P, Heldin C. A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J 1991;10:1091-1101.
29. Kinnman N, Andersson U, Hultcrantz R. In situ expression of transforming growth factor-beta1-3, latent transforming growth factor-beta binding protein and tumor necrosis factor-alpha in liver tissue from patients with chronic hepatitis C. Scand J Gastroenterol 2000;35:1294-1300.
30. Hsiao EC, Koniaris LG, Zimmers-Koniaris T, Sebald SM, Huynh TV, Lee SJ. Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol 2000;20:3742-3751.
31. Lee DK, Park SH, Yi Y, Choi SG, Lee C, Parks WT, et al. The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev 2001;15:455-466.
32. Neubauer K, Saile B, Ramadori G. Liver fibrosis and altered matrix synthesis. Can J Gastroenterol 2001;15:187-193.
33. Yabu K, Kiyosawa K, Mori H, Matsumoto A, Yoshizawa K, Tanaka E, et al. Serum collagen type IV for the assessment of fibrosis and resistance to interferon therapy in chronic hepatitis C. Scand J Gastroenterol 1994;29:474-479.
34. Kaplanski G, Farnarier C, Payan MJ, Bongrand P, Durand JM. Increased levels of soluble adhesion molecules in the serum of patients with hepatitis C. Correlation with cytokine concentrations and liver inflammation and fibrosis. Dig Dis Sci 1997;42:2277-2284.
35. Park KJ, Choi SH, Lee SY, Hwang SB, Lai MMC. Nonstructural 5A protein of hepatitis C virus modulates TNF-alpha-stimulated NF-kappa B activation. J Biol Chem 2002;277:13122-13128.
36. Majumder M, Ghosh AK, Steele R, Zhou XY, Phillips NJ, Ray R, et al. Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. Virology 2002;294:94-105.
37. Kato A, Yoshidome H, Edwards MJ, Lentsch AB. Regulation of liver inflammatory injury by signal transducer and activator of transcription-6. Am J Pathol 2000;157:297-302.
38. Armant M, Avice MN, Hermann P, Rubio M, Kiniwa M, Delespesse G, et al. CD47 ligation selectively downregulates human interleukin 12 production. J Exp Med 1999;190:1175-1182.
39. Lu HT, Yang DD, Wysk M, Gatti E, Mellman I, Davis RJ, et al. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J 1999;18:1845-1857.
40. Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 1999;162:5584-5591.
41. Gong G, Waris G, Tanveer R, Siddiqui A. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci U S A 2001;98:9599-9604.
42. Wunschmann S, Medh JD, Klinzmann D, Schmidt WN, Stapleton JT. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol 2000;74:10055-10062.
43. Andre P, Komurian-Pradel F, Deforges S, Perret M, Berland JL, Sodoyer M, et al. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 2002;76:6919-6928
44. Wozniak MA, Itzhaki RF, Faragher EB, James MW, Ryder SD, Irving WL. Apolipoprotein E-ε4 protects against severe liver disease caused by hepatitis C virus. HEPATOLOGY 2002;36:456-463.
45. Shi ST, Polyak SJ, Tu H, Taylor DR, Gretch DR, Lai MM. Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 2002;292:198-210.
46. Schindler U, Baichwal VR. Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol Cell Biol 1994;14:5820-5831.
47. Gong G, Waris G, Tanveer R, Siddiqui A. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-KappaB. Proc Natl Acad Sci U S A 2001;98:9599-9604.
48. Boya P, Larrea E, Sola I, Majano P-L, Jimenez C, Civeira M-P, et al. Nuclear factor-kB in the liver of patients with chronic hepatitis C: decreased RelA expression is associated with enhanced fibrosis progression. HEPATOLOGY 2001;34:1041-1048.